Cargando…
Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer
Blood‐based protein biomarkers may be an attractive option for early detection of colorectal cancer (CRC). Here, we used a two‐stage design to measure 275 protein markers by proximity extension assay (PEA), first in plasma samples of a discovery set consisting of 98 newly diagnosed CRC cases and 100...
Autores principales: | Bhardwaj, Megha, Weigl, Korbinian, Tikk, Kaja, Benner, Axel, Schrotz‐King, Petra, Brenner, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944100/ https://www.ncbi.nlm.nih.gov/pubmed/31652396 http://dx.doi.org/10.1002/1878-0261.12591 |
Ejemplares similares
-
Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019) -
Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening
por: Bhardwaj, Megha, et al.
Publicado: (2022) -
Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
por: Qian, Jing, et al.
Publicado: (2018) -
Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017) -
Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart
por: Bhardwaj, Megha, et al.
Publicado: (2022)